During the COVID-19 pandemic, it was observed that patients with heart disease are more likely to be hospitalized and develop severe COVID-19. Cardiac disease takes the top position among patient comorbidities, heart failure (HF) prevalence reaching almost 5% in the general population older than 35 years in Romania. This retrospective study aimed to determine the potential use of the NYHA classification for HF in hospitalized patients with COVID-19 as prognostic tool for in-hospital mortality, length of hospitalization, and probability of rehospitalization for HF decompensation. We observed that patients with advanced HF had a history of significantly more comorbid conditions that are associated with worse disease outcomes than the rest of patients classified as NYHA I and II. However, regardless of existing diseases, NYHA III, and, especially, NYHA IV, patients were at greatest risk for mortality following SARS-CoV-2 infection. They required significantly longer durations of hospitalization, ICU admission for mechanical ventilation, and developed multiple severe complications. NYHA IV patients required a median duration of 20 days of hospitalization, and their in-hospital mortality was as high as 47.8%. Cardiac biomarkers were significantly altered in patients with SARS-CoV-2 and advanced HF. Although the study sample was small, all patients with NYHA IV who recovered from COVID-19 required a rehospitalization in the following month, and 65.2% of the patients at initial presentation died during the next six months. The most significant risk factor for mortality was the development of severe in-hospital complications (OR = 4.38), while ICU admission was the strongest predictor for rehospitalization (OR = 5.19). Our result highlights that HF patients continue to be vulnerable post SARS-CoV-2 infection. Physicians and policymakers should consider this population’s high likelihood of hospital readmissions when making discharge, hospital capacity planning, and post-discharge patient monitoring choices.
【저자키워드】 COVID-19, SARS-CoV-2, heart failure, mortality risk, NYHA classification, rehospitalization, 【초록키워드】 Biomarker, Diseases, Hospitalized, Mortality, severe COVID-19, mechanical ventilation, Hospitalization, SARS-COV-2 infection, COVID-19 pandemic, hospital, Comorbidities, risk, outcome, risk factor, discharge, Prevalence, Probability, Retrospective study, Patient, ICU admission, General population, Romania, prognostic, disease, in-hospital mortality, readmission, cardiac, Older, severe complications, physician, likelihood, highlight, initial, develop, significantly more, died, significantly, the patient, required, median, determine, hospitalized patient, comorbid condition, in-hospital complication, patients with SARS-CoV-2, with COVID-19, 【제목키워드】 classification, Forecasting, heart, failure, with COVID-19,